A recent research has proved that increased survival in colorectal cancer is possible with the use of a popular indigestion medication. But in fact, scientists have studied this for years - and a group of cancer advocates want to know why this research isn't more widely used.
"Cimetidine is an interesting drug as it's very safe, very well-known, and has clinical results in cancer that have been confirmed in a number of trials," says Pan Pantziarka, lead author of the paper and member of the Repurposing Drugs in Oncology (ReDO) project.
First-in-Class Drugs in Pipeline for Non-Small Cell Lung Cancer
Newer drugs are in the pipeline for the treatment of Non-Small Cell Lung Cancer (NSCLC) which will provide targeted treatment and hopefully improve the prognosis of patients with lung cancer.
Advertisement
Cimetidine treats indigestion by blocking histamine receptors in the gut, which decreases the production of gastric acid. It also appears to block histamine receptors in cancer cells, as well as supporting the immune system's defences against cancer. Cimetidine has been shown to have positive effects in colorectal and gastric cancer, melanoma, and renal cell carcinoma.
"Cimetidine is one of the most interesting examples of repurposed drugs in oncology - a drug with an extensive history of pre-clinical and clinical evidence of efficacy in a range of different cancers and with multiple mechanisms of action at work," says Pantziarka.
![Genetic Test Can Become a Game Changer in Identified Aggressive Prostate Cancers]( "Genetic Test Can Become a Game Changer in Identified Aggressive Prostate Cancers")
Prostate cancer is the leading cause of death among men but a new genetic test can help identify bad cancer early.
Raising awareness of untapped medicines:
An international collaboration between anticancer researchers from across the world, the ReDO project is dedicated to promoting the cause of common medicines which may represent an untapped source of novel therapies for cancer.
In a previous paper published in ecancermedicalscience, the ReDO researchers examined the anti-cancer properties of the drug mebendazole, an over-the-counter treatment currently used for threadworm.
Now, working in partnership with ecancer, the ReDO project is publishing a series of papers on drugs with enough evidence to be taken to clinical trials. Future papers will address the potential anti-cancer uses of nitroglycerin (used to treat angina), itraconazole (a common anti-fungal), diclofenac (an over-the-counter painkiller), and clarithromycin (an antibiotic).
"Such promising therapies are often ignored since pharmaceutical companies lack financial incentives to develop them further via proper clinical trials," says Gauthier Bouche, medical director of Anticancer Fund. "The ReDO project was established to find and document such opportunities."
A cheaper solution to the cancer crisis:
Repurposed anticancer drugs such as aspirin and antacids may represent the future of cancer drug research, according to leaders of the ReDO project.
Cheap, accessible, and with few side-effects, these solutions are very attractive to healthcare professionals in low and middle-income countries. Repurposed drugs could also reduce the financial burden of cancer in developed countries.
"Cimetidine is a drug that can meet patient needs now - so we need to ask ourselves: what's stopping it being used?" asks Pantziarka.
Source: Eurekalert
Genetic Test Can Become a Game Changer in Identified Aggressive Prostate Cancers
Prostate cancer is the leading cause of death among men but a new genetic test can help identify bad cancer early.
Advertisement
Raising awareness of untapped medicines:
An international collaboration between anticancer researchers from across the world, the ReDO project is dedicated to promoting the cause of common medicines which may represent an untapped source of novel therapies for cancer.
In a previous paper published in ecancermedicalscience, the ReDO researchers examined the anti-cancer properties of the drug mebendazole, an over-the-counter treatment currently used for threadworm.
Now, working in partnership with ecancer, the ReDO project is publishing a series of papers on drugs with enough evidence to be taken to clinical trials. Future papers will address the potential anti-cancer uses of nitroglycerin (used to treat angina), itraconazole (a common anti-fungal), diclofenac (an over-the-counter painkiller), and clarithromycin (an antibiotic).
"Such promising therapies are often ignored since pharmaceutical companies lack financial incentives to develop them further via proper clinical trials," says Gauthier Bouche, medical director of Anticancer Fund. "The ReDO project was established to find and document such opportunities."
A cheaper solution to the cancer crisis:
Repurposed anticancer drugs such as aspirin and antacids may represent the future of cancer drug research, according to leaders of the ReDO project.
Cheap, accessible, and with few side-effects, these solutions are very attractive to healthcare professionals in low and middle-income countries. Repurposed drugs could also reduce the financial burden of cancer in developed countries.
"Cimetidine is a drug that can meet patient needs now - so we need to ask ourselves: what's stopping it being used?" asks Pantziarka.
Source: Eurekalert
Early Detection Beneficial When Pancreatic Cancer Runs in the Family
Pancreatic cancer is a deadly form of cancer with a very high mortality rate. New research shows that early detection of pancreatic cancer offers a better chance of long-term survival.
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Cancer News
New study evaluated the association between exposure to the chemical agent orange and the development of blood cancer with increased bleeding and blood clot formation.
Study suggests two-year immunotherapy treatment for advanced lung cancer may be reasonable
A ray of hope for glioma patients as targeted therapy boosts treatment duration.
In patients with breast cancer combination therapy had increased invasive disease-free survival compared to those who were treated with the hormone therapy alone.
An antibody treatment helped shrink tumors in some patients with bile duct cancers.